GTC Biotherapeutics (fka GTCB)

[silly beaver]

I hope you are right Dew. But with GTCB sitting at a 52 week low the market is telling me that it is pricing in failure and some sort of toxic financing that isn't shareholder friendly. The market seems to be betting on the scenario I mentioned rather than success and a U.S. partnership. Do you fear this happening? I guess these risks are what makes the potential upside so huge. Your thoughts are most appreciated.